Metabolomic analysis in severe childhood pneumonia in The Gambia, West Africa: Findings from a pilot study

PLoS ONE

Volumn 5, Issue 9, 2010, Pages 1-9

  Laiakis, Evagelia C ^a   Morris, Gerard A J ^b   Fornace, Albert J ^a,c   Howie, Stephen R C ^b  

^a GEORGETOWN UNIVERSITY   (United States)

^b Bacterial Diseases Programme   (United States)

^c Dankook University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; GLUTAMIC ACID; HISTIDINE; HYPOXANTHINE; TRYPTOPHAN; URIC ACID; BIOLOGICAL MARKER;

ARTICLE; BLOOD LEVEL; CHILD; CHILD HEALTH; CHILDHOOD PNEUMONIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GAMBIA; HUMAN; MALE; METABOLOMICS; MULTIVARIATE ANALYSIS; ORTHOGONAL PROJECTION TO LATENT STRUCTURES; PARTIAL LEAST SQUARES DISCRIMINANT ANALYSIS; PILOT STUDY; PNEUMONIA; PRESCHOOL CHILD; PRINCIPAL COMPONENT ANALYSIS; RANDOM FOREST; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINE LEVEL; ADOLESCENT; BLOOD; GENETICS; HAEMOPHILUS INFLUENZAE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOLATION AND PURIFICATION; MICROBIOLOGY; STREPTOCOCCUS PNEUMONIAE; URINE;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GAMBIA; HAEMOPHILUS INFLUENZAE; HUMANS; MALE; METABOLOMICS; PILOT PROJECTS; PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

EID: 77958613720     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012655     Document Type: Article

References (58)

1. Black RE, Morris SS, Bryce J (2003) Where and why are 10 million children dying every year? Lancet 361: 2226-2234.
2. Garenne M, Ronsmans C, Campbell H (1992) The magnitude of mortality from acute respiratory infections in children under 5 years in developing countries. World Health Stat Q 45: 180-191.
3. Mathers C SC, Fat D. Global Burden of Disease 2000: version 2, methods and results.
4. Mulholland K (2003) Global burden of acute respiratory infections in children: implications for interventions. Pediatr Pulmonol 36: 469-474.
5. Mulholland K (2007) Childhood pneumonia mortality-a permanent global emergency. Lancet 370: 285-289.
6. Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H (2008) Epidemiology and etiology of childhood pneumonia. Bull World Health Organ 86: 408-416.
7. WHO (2003) Draft Report of Consultative Meeting to Review Evidence and Research Priorities in Management of Acute Respiratory Infections (ARI). Geneva: World Health Organization Report No.: WHO/FCH/CAH/03.9.
8. Wold Health Organization (2002) Revised Global Burden of Disease (GBD) 2002. Estimates in Geneva: WHO; p.2005.
9. Greenwood BM, Greenwood AM, Bradley AK, Tulloch S, Hayes R, et al. (1987) Deaths in infancy and early childhood in a well-vaccinated, rural, West African population. Ann Trop Paediatr 7: 91-99.
10. Jaffar S, Leach A, Greenwood AM, Jepson A, Muller O, et al. (1997) Changes in the pattern of infant and childhood mortality in upper river division, The Gambia, from 1989 to 1993. Trop Med Int Health 2: 28-37.
11. Greenwood B (2008) A global action plan for the prevention and control of pneumonia. Bull World Health Organ 86: 322-32A.
12. Secretary General of the United Nations (2001) Road Map Towards the Implementation of the United Nations Millenium Declaration: Report of Secretary General to Fifty-Sixth Session of the United Nations General Assembly.
13. Qazi S WM, Boschi-Pinto C, Cherian T (2008) Global Action Plan for the Prevention and Control of Pneumonia (GAPP): Report of an Informal Consultation: La Mainaz, Gex, France, 5-7 March 2007. World Health Organization.
14. Howie SR, Adegbola RA (2006) Pneumonia and child mortality. Lancet 368: 1646.
15. Scott JA, English M (2008) What are the implications for childhood pneumonia of successfully introducing Hib and pneumococcal vaccines in developing countries? PLoS Med 5: e86.
16. Lanz C, Patterson AD, Slavik J, Krausz KW, Ledermann M, et al. (2009) Radiation metabolomics. 3. Biomarker discovery in the urine of gammairradiated rats using a simplified metabolomics protocol of gas chromatographymass spectrometry combined with random forests machine learning algorithm. Radiat Res 172: 198-212.
17. Patterson AD, Li H, Eichler GS, Krausz KW, Weinstein JN, et al. (2008) UPLCESI-TOFMS-based metabolomics and gene expression dynamics inspector selforganizing metabolomic maps as tools for understanding the cellular response to ionizing radiation. Anal Chem 80: 665-674.
18. Tyburski JB, Patterson AD, Krausz KW, Slavik J, Fornace AJJ, et al. (2008) Radiation metabolomics. 1. Identification of minimally invasive urine biomarkers for gamma-radiation exposure in mice. Radiat Res 170: 1-14.
19. Tyburski JB, Patterson AD, Krausz KW, Slavik J, Fornace AJJ, et al. (2009) Radiation metabolomics. 2. Dose- and time-dependent urinary excretion of deaminated purines and pyrimidines after sublethal gamma-radiation exposure in mice. Radiat Res 172: 42-57.
20. Griffin JL, Kauppinen RA (2007) Tumour metabolomics in animal models of human cancer. J Proteome Res 6: 498-505.
21. Jordan KW, Cheng LL (2007) NMR-based metabolomics approach to target biomarkers for human prostate cancer. Expert Rev Proteomics 4: 389-400.
22. Serkova NJ, Glunde K (2009) Metabolomics of cancer. Methods Mol Biol 520: 273-295.
23. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, et al. (2009) Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457: 910-914.
24. Jansson J, Willing B, Lucio M, Fekete A, Dicksved J, et al. (2009) Metabolomics reveals metabolic biomarkers of Crohn's disease. PLoS One 4: e6386.
25. Kinross J, von Roon AC, Penney N, Holmes E, Silk D, et al. (2009) The gut microbiota as a target for improved surgical outcome and improved patient care. Curr Pharm Des 15: 1537-1545.
26. Tuohy KM, Gougoulias C, Shen Q, Walton G, Fava F, et al. (2009) Studying the human gut microbiota in the trans-omics era-focus on metagenomics and metabonomics. Curr Pharm Des 15: 1415-1427.
27. Waldram A, Holmes E, Wang Y, Rantalainen M, Wilson ID, et al. (2009) Topdown systems biology modeling of host metabotype-microbiome associations in obese rodents. J Proteome Res 8: 2361-2375.
28. Cassiday L (2009) Diagnosing pneumonia with urinary metabolomics. J Proteome Res 8: 5409-5410.
29. Mahadevan S, Shah SL, Marrie TJ, Slupsky CM (2008) Analysis of metabolomic data using support vector machines. Anal Chem 80: 7562-7570.
30. Slupsky CM, Rankin KN, Fu H, Chang D, Rowe BH, et al. (2009) Pneumococcal pneumonia: potential for diagnosis through a urinary metabolic profile. J Proteome Res 8: 5550-5558.
31. Serkova NJ, Van Rheen Z, Tobias M, Pitzer JE, Wilkinson JE, et al. (2008) Utility of magnetic resonance imaging and nuclear magnetic resonance-based metabolomics for quantification of inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol 295: L152-61.
32. Slupsky CM, Cheypesh A, Chao DV, Fu H, Rankin KN, et al. (2009) Streptococcus pneumoniae and Staphylococcus aureus pneumonia induce distinct metabolic responses. J Proteome Res 8: 3029-3036.
33. Gambian Central Statistics Department (2003) 2003 Census.
34. Adegbola RA, Falade AG, Sam BE, Aidoo M, Baldeh I, et al. (1994) The etiology of pneumonia in malnourished and well-nourished Gambian children. Pediatr Infect Dis J 13: 975-982.
35. Morris GA, Ikumapayi UN, Antonio M, Howie SR, Adegbola RA (2008) A novel Campylobacter jejuni sequence type from a culture-negative patient in the Gambia. PLoS One 3: e1773.
36. Smith-Vaughan H, Byun R, Nadkarni M, Jacques NA, Hunter N, et al. (2006) Measuring nasal bacterial load and its association with otitis media. BMC Ear Nose Throat Disord 6: 10.
37. Breiman L (2001) Random Forests. Machine Learning 45: 5-32.
38. Patterson AD, Lanz C, Gonzalez FJ, Idle JR (2009) The role of mass spectrometry-based metabolomics in medical countermeasures against radiation. Mass Spectrom Rev.
39. Becker BF (1993) Towards the physiological function of uric acid. Free Radic Biol Med 14: 615-631.
40. Mene P, Punzo G (2008) Uric acid: bystander or culprit in hypertension and progressive renal disease? J Hypertens 26: 2085-2092.
41. Gasse P, Riteau N, Charron S, Girre S, Fick L, et al. (2009) Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis. Am J Respir Crit Care Med 179: 903-913.
42. Rodriguez-Nunez A, Camina F, Lojo S, Rodriguez-Segade S, Castro-Gago M (1993) Concentrations of nucleotides, nucleosides, purine bases and urate in cerebrospinal fluid of children with meningitis. Acta Paediatr 82: 849-852.
43. Schmidt H, Weigand MA, Li C, Schmidt W, Martin E, et al. (1997) Intestinal formation of hypoxanthine and uric acid during endotoxemia. J Surg Res 71: 61-66.
44. Jabs CM, Neglen P, Eklof B (1995) Breakdown of adenine nucleotides, formation of oxygen free radicals, and early markers of cellular injury in endotoxic shock. Eur J Surg 161: 147-155.
45. Fabre JE, Nguyen M, Latour A, Keifer JA, Audoly LP, et al. (1999) Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat Med 5: 1199-1202.
46. Gear AR, Suttitanamongkol S, Viisoreanu D, Polanowska-Grabowska RK, Raha S, et al. (2001) Adenosine diphosphate strongly potentiates the ability of the chemokines MDC, TARC, and SDF-1 to stimulate platelet function. Blood 97: 937-945.
47. Murugappan S, Kunapuli SP (2006) The role of ADP in platelet function. Frontiers in Bioscience 11: 1977-1986.
48. Hendriksen WT, Kloosterman TG, Bootsma HJ, Estevao S, de Groot R, et al. (2008) Site-specific contributions of glutamine-dependent regulator GlnR and GlnR-regulated genes to virulence of Streptococcus pneumoniae. Infect Immun 76: 1230-1238.
49. Yue S, Lou Z, Yu P, Zeng P. Changes in glutamate and GABA in cerebrospinal fluid of patients with pneumonia complicated with central nervous system damag. Hunan Yi Ke Da Xue Xue Bao 24: 287-289.
50. Muller A, Heseler K, Schmidt SK, Spekker K, Mackenzie CR, et al. (2008) The missing link between indoleamine 2,3-dioxygenase mediated antibacterial and immunoregulatory effects. J Cell Mol Med.
51. Xu X, Zhang D, Zhang H, Wolters PJ, Killeen NP, et al. (2006) Neutrophil histamine contributes to inflammation in mycoplasma pneumonia. J Exp Med 203: 2907-2917.
52. Burian K, Hegyesi H, Buzas E, Endresz V, Kis Z, et al. (2003) Chlamydophila (Chlamydia) pneumoniae induces histidine decarboxylase production in the mouse lung. Immunol Lett 89: 229-236.
53. Combes A, Luyt CE, Trouillet JL, Nieszkowska A, Chastre J (2009) Gender impact on the outcomes of critically ill patients with nosocomial infections. Crit Care Med 37: 2506-2511.
54. Reade MC, Yende S, D'Angelo G, Kong L, Kellum JA, et al. (2009) Differences in immune response may explain lower survival among older men with pneumonia. Crit Care Med 37: 1655-1662.
55. Casimir GJ, Mulier S, Hanssens L, Zylberberg K, Duchateau J (2009) GENDER DIFFERENCES IN INFLAMMATORY MARKERS IN CHILDREN. Shock.
56. Henderson JP, Crowley JR, Pinkner JS, Walker JN, Tsukayama P, et al. (2009) Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli. PLoS Pathog 5: e1000305.
57. Himmelreich U, Malik R, Kuhn T, Daniel HM, Somorjai RL, et al. (2009) Rapid etiological classification of meningitis by NMR spectroscopy based on metabolite profiles and host response. PLoS One 4: e5328.
58. Sintchenko V, Iredell JR, Gilbert GL (2007) Pathogen profiling for disease management and surveillance. Nat Rev Microbiol 5: 464-470.